153 related articles for article (PubMed ID: 15791686)
21. Prediction of the coupling specificity of GPCRs to four families of G-proteins using hidden Markov models and artificial neural networks.
Sgourakis NG; Bagos PG; Hamodrakas SJ
Bioinformatics; 2005 Nov; 21(22):4101-6. PubMed ID: 16174684
[TBL] [Abstract][Full Text] [Related]
22. Hybrid approach for the design of highly affine and selective dopamine D(3) receptor ligands using privileged scaffolds of biogenic amine GPCR ligands.
Sasse BC; Mach UR; Leppaenen J; Calmels T; Stark H
Bioorg Med Chem; 2007 Dec; 15(23):7258-73. PubMed ID: 17826096
[TBL] [Abstract][Full Text] [Related]
23. Modeling small molecule-compound binding to G-protein-coupled receptors.
Vaidehi N; Pease JE; Horuk R
Methods Enzymol; 2009; 460():263-88. PubMed ID: 19446730
[TBL] [Abstract][Full Text] [Related]
24. I want a new drug: G-protein-coupled receptors in drug development.
Schlyer S; Horuk R
Drug Discov Today; 2006 Jun; 11(11-12):481-93. PubMed ID: 16713899
[TBL] [Abstract][Full Text] [Related]
25. Molecular biology of 5-HT receptors.
Hannon J; Hoyer D
Behav Brain Res; 2008 Dec; 195(1):198-213. PubMed ID: 18571247
[TBL] [Abstract][Full Text] [Related]
26. Finding ligands for G protein-coupled receptors based on the protein-compound affinity matrix.
Fukunishi Y; Kubota S; Nakamura H
J Mol Graph Model; 2007 Jan; 25(5):633-43. PubMed ID: 16777448
[TBL] [Abstract][Full Text] [Related]
27. G protein-coupled receptors, an unexploited animal toxin targets: Exploration of green mamba venom for novel drug candidates active against adrenoceptors.
Maïga A; Mourier G; Quinton L; Rouget C; Gales C; Denis C; Lluel P; Sénard JM; Palea S; Servent D; Gilles N
Toxicon; 2012 Mar; 59(4):487-96. PubMed ID: 21419153
[TBL] [Abstract][Full Text] [Related]
28. Coupling interaction between thromboxane A2 receptor and alpha-13 subunit of guanine nucleotide-binding protein.
Chou KC
J Proteome Res; 2005; 4(5):1681-6. PubMed ID: 16212421
[TBL] [Abstract][Full Text] [Related]
29. The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain.
Burchett SA; Hicks TP
Prog Neurobiol; 2006 Aug; 79(5-6):223-46. PubMed ID: 16962229
[TBL] [Abstract][Full Text] [Related]
30. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
Bhattacharya S; Hall SE; Vaidehi N
J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
[TBL] [Abstract][Full Text] [Related]
31. A renaissance in trace amines inspired by a novel GPCR family.
Lindemann L; Hoener MC
Trends Pharmacol Sci; 2005 May; 26(5):274-81. PubMed ID: 15860375
[TBL] [Abstract][Full Text] [Related]
32. Conformational complexity of G-protein-coupled receptors.
Kobilka BK; Deupi X
Trends Pharmacol Sci; 2007 Aug; 28(8):397-406. PubMed ID: 17629961
[TBL] [Abstract][Full Text] [Related]
33. Virtual screen for ligands of orphan G protein-coupled receptors.
Bock JR; Gough DA
J Chem Inf Model; 2005; 45(5):1402-14. PubMed ID: 16180917
[TBL] [Abstract][Full Text] [Related]
34. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
Huber T; Menon S; Sakmar TP
Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
[TBL] [Abstract][Full Text] [Related]
35. Homology model-based virtual screening for GPCR ligands using docking and target-biased scoring.
Radestock S; Weil T; Renner S
J Chem Inf Model; 2008 May; 48(5):1104-17. PubMed ID: 18442221
[TBL] [Abstract][Full Text] [Related]
36. Recognition of GPCRs by peptide ligands and membrane compartments theory: structural studies of endogenous peptide hormones in membrane environment.
Sankararamakrishnan R
Biosci Rep; 2006 Apr; 26(2):131-58. PubMed ID: 16773462
[TBL] [Abstract][Full Text] [Related]
37. 7-Arylpiperazinylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and some of their purine-2,6,8-trione analogs as 5-HT(1A), 5-HT(2A), and 5-HT(7) serotonin receptor ligands.
Chłoń-Rzepa G; Zmudzki P; Zajdel P; Bojarski AJ; Duszyńska B; Nikiforuk A; Tatarczyńska E; Pawłowski M
Bioorg Med Chem; 2007 Aug; 15(15):5239-50. PubMed ID: 17517514
[TBL] [Abstract][Full Text] [Related]
38. "Phenotypic" pharmacology: the influence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology.
Nelson CP; Challiss RA
Biochem Pharmacol; 2007 Mar; 73(6):737-51. PubMed ID: 17046719
[TBL] [Abstract][Full Text] [Related]
39. In silico identification of novel G protein coupled receptors.
Davies MN; Flower DR
Methods Mol Biol; 2009; 528():25-36. PubMed ID: 19153682
[TBL] [Abstract][Full Text] [Related]
40. Extracellular loops and ligand binding to a subfamily of Family A G-protein-coupled receptors.
Wheatley M; Simms J; Hawtin SR; Wesley VJ; Wootten D; Conner M; Lawson Z; Conner AC; Baker A; Cashmore Y; Kendrick R; Parslow RA
Biochem Soc Trans; 2007 Aug; 35(Pt 4):717-20. PubMed ID: 17635132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
